Literature DB >> 25984975

A Standardized Assessment of Functional Disability Predicts 1-year Mortality in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.

Douglas Grunwald1, Elliot B Tapper, Zhenghui Gordon Jiang, Muneeb Ahmed, Raza Malik.   

Abstract

GOALS: To determine the association between functional disability and mortality after transjugular intrahepatic portosystemic shunt (TIPS).
BACKGROUND: TIPS is a common therapeutic procedure for cirrhotic patients with refractory ascites. The conventional metric for periprocedure risk stratification is the model for end-stage liver disease (MELD), which uses biochemical parameters to predict post-TIPS mortality. It does not account for functional disability. STUDY: This is a retrospective cohort study of 83 patients admitted at an academic liver transplant center with cirrhosis and refractory ascites for the purpose of TIPS placement. We assessed the association of patients' reported activities of daily living (ADL) on a scale of 1 to 21 before TIPS with a primary outcome of 1-year mortality. Multivariable regression to adjust for MELD and Child class was performed.
RESULTS: A higher ADL score or functional independence, was associated with decreased 1-year mortality when modeled as both a continuous variable [odds ratio (OR), 0.80; 95% confidence interval (CI), 0.66-0.97; P=0.02) and a dichotomous variable (ADL 21 vs. <21; OR, 0.21; 95% CI, 0.05-0.70; P=0.01). After adjusting for MELD and Child class, functional independence was associated with decreased 1-year transplant-free mortality (OR, 0.22; 95% CI, 0.05-0.77; P=0.02). An ADL score consistent with dependence (<21) was significantly associated with a 3.40-day (95% CI, 1.76-5.04) longer hospital stay, adjusting for MELD and Child class (P<0.0001).
CONCLUSIONS: Functional disability is a predictor of post-TIPS mortality and length of stay after controlling for MELD.

Entities:  

Mesh:

Year:  2016        PMID: 25984975     DOI: 10.1097/MCG.0000000000000339

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.

Authors:  Edward Wolfgang Lee; Andrew Kuei; Sammy Saab; Ronald W Busuttil; Francisco Durazo; Steven-Huy Han; Mohamed M El-Kabany; Justin P McWilliams; Stephen T Kee
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding.

Authors:  Yue-Meng Wan; Yu-Hua Li; Zhi-Yuan Xu; Hua-Mei Wu; Xi-Nan Wu; Ying Xu
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315

3.  Design and rationale of a randomized-controlled trial of home-delivered meals for the management of symptomatic ascites: the SALTYFOOD trial.

Authors:  Elliot B Tapper; Jad Baki; Scott Hummel; Anna Lok
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-03-11

4.  Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt.

Authors:  Dongmei Zhao; Guobing Zhang; Mingquan Wang; Chaoxue Zhang; Jiabin Li
Journal:  Clin Mol Hepatol       Date:  2019-03-22

5.  Guidelines on the management of ascites in cirrhosis.

Authors:  Guruprasad P Aithal; Naaventhan Palaniyappan; Louise China; Suvi Härmälä; Lucia Macken; Jennifer M Ryan; Emilie A Wilkes; Kevin Moore; Joanna A Leithead; Peter C Hayes; Alastair J O'Brien; Sumita Verma
Journal:  Gut       Date:  2020-10-16       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.